Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Time-series are combined where methods are similar over the time span. In some countries data are insufficient to report.
Target groups may vary between countries owing to different methods and data sources; therefore comparisons should be made with caution.
The estimates of Czech Republic refer to the age group 18-64.
SB2006: Figure PDU-4 part (i)
For more details see Tables PDU-1 to PDU-3 in the 2007 Statistical Bulletin.
See also 'General notes for interpreting data' on the Explanatory notes and help page.
See also EMCDDA project (2003): National prevalence estimates of problem drug use in the European Union, 1995–2000, CT.00.RTX.23, EMCDDA, Lisbon, coordinated by the Institut für Therapieforschung, Munich (http://www.emcdda.eu.int/?nnodeid=1372).
National Focal Points.
Page last updated: Friday, 23 November 2007